Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Bioinformatics: Technologies and Global Markets 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.
The high growth rate of this segment is attributed to factors such as the demand for antibodies research, the expanding COVID-19 pandemic, epidemics of other infectious diseases, and an increase in R&D activities by key companies to develop new data regarding genetic consequences to counter the rise in different infectious diseases globally.
Moreover, the advancement of biological discoveries will result in the need for more molecular targets to be detected by their antibodies and the usage of different bioinformatic tools. For example, publicly available datasets of human BCR were selected to represent different sequencing platforms such as Illumina MiSeq, Roche 454, and Ion Torrent.
Sample preparation protocols, data quality and disease status information are also required during sequencing. The use of different tools manufactured by key players is likely to propel the growth of the bioinformatics market during the forecast period.
Genomics continues to attract significant investment from public and private funds, which has fueled the development of subdisciplines such as chemogenomics, metagenomics, pharmacogenomics and toxicogenomics. Further advances in high-throughput technologies have led to a decline in sequencing costs and an increase in data generation. The rapid evolution of cloud-based solutions has helped address some IT infrastructure issues relating to data storage and retrieval, although challenges remain with respect to data security.
Proteomics is increasingly gaining pace and offers considerable potential, particularly to the pharma industry, as the vast number of approved drugs act directly on protein targets, and the development of biologics and orphan drugs is high on pharma radar.
For instance, according to the Journal of Proteome Research, the Human Proteome Organization (HUPO) has a working group, the Proteomics Standards Initiative (PSI), whose mission is to define data standards for proteomics.
HUPO is also exploring the application of proteomics for the purpose of integrating it with genomics and transcriptomics across the life sciences and biomedical research. Advances in proteomics and the interpretation of multiplexed proteomics data will continue to attract investment from the industry.
The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market.
It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.
Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa will be covered in the regional segment.
For market estimates, data will be provided for 2019 as the base year, with estimates for 2020 and forecast value for 2025.
Key Topics Covered:
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Biological Data Sources
Bioinformatics in Systems Biology
Bioinformatics in Precision Medicine
Bioinformatics in Drug Development
Bioinformatics in Metagenomics
Bioinformatics in Database Management Systems
Precision Medicine and Biomarker Identification
Shift Toward Value-Based Care
Data Reliability and Standardization
Market Trends in Bioinformatics Tools and Software
Purchasing Factors Analysis
Analyzing Experimental Data
Chapter 4 Research Funding for Bioinformatics
Chapter 5 Market Dynamics
New Discoveries in Biological Sciences
Increasing Use of Bioinformatics Analytical Software
New Antibody Technologies and Antibody Types
Antibody-Based Drug Discovery and Development
Developed and Increasing Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
New Application-Focused Technology Platforms
Challenging Issues of Modeling Systems
Ethical Concerns of Bioinformatics and Computational Genomics
Market Expansion into Emerging Countries
Development of Novel Bioinformatics and Drugs
Chapter 6 Market Breakdown by Application
Software Scalability and Validity
Global Market for Bioinformatics by Application
Chapter 7 Market for Sequencing Services and Platforms
Global Market for Sequencing Services and Platforms
Chapter 8 Market Breakdown by Solution
Global Market for Bioinformatics by Solution
Bioinformatic Tools and Database Services
Database Management Services
IT Hardware and Infrastructure
Chapter 9 Market Breakdown by End User
Global Market for Bioinformatics by End User
Clinical and Medical
Other End Users
Chapter 10 Market Breakdown by Region
Global Market for Bioinformatics by Region
Rest of the World
Chapter 11 Impact of COVID-19 on the Pharmaceutical/Biotechnology Industry
Change in Demand
Shift of Communication and Promotions to Remote Interactions
Research and Development Changes
Delayed Approvals for Non-COVID-Related Pharmaceutical/Biotech Products
Self-Sufficiency in Pharma/Biotech Industry
Pharmaceutical Industry Growth Slow-Down
Changes in Consumption Trends in Health-Related Products
Chapter 12 Bioinformatics Applications in Pharmaceutical R&D
Drug Discovery and Development Process
Clinical Research: Drug Development
Investigational New Drug Applications
New Drug Application
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Electronic Health Records
Mobile Health Technologies
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Chapter 13 Competitive Landscape
Global Company Market Ranking Analysis
Chapter 14 Company Profiles
3rd Millennium Inc.
Agilent Technologies Inc.
Biomatters Ltd. Geneious
Bio-Rad (Abd Serotec)
Dassault Systemes Biovia
Geneva Bioformatics (Genebio) Sa
Genomatix Software Gmbh
Gns Healthcare Inc.
GVK Biosciences Pvt. Ltd.
Inte:Ligand Software Entwicklungs Und Consulting Gmbh
Molecular Connections Pvt. Ltd.
Molecular Networks Gmbh
Nonlinear Dynamics Ltd.
Ocimum Biosolutions Ltd.
Perkinelmer Informatics Inc.
Real Time Genomics Inc.
Smartgene Services Sarl
Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/v63mr9
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900